Welcome to The Technocrats Episode 14: Weathering the Storm: Why Supply Chain Resilience is always in season? Part II. This episode underscores that supply chain resiliency is essential for businesses to thrive amid disruptions and achieve financial success.
Deepak Mittal and Duane Kotsen discuss the importance of supply chain resiliency. Leading companies with strong supply chains report better financial performance, using practices like diversified sourcing, robust risk management, and strong supplier relationships. AI and machine learning enhance resiliency by improving forecasting accuracy and optimizing inventory. Future trends include increased tech investment, sustainability, enhanced collaboration, and sophisticated risk management. Duane emphasizes the necessity of supply chain resiliency and highlights upcoming industry events showcasing new innovations.
Tune in to our podcast now on Spotify and Apple Podcasts to gain valuable insights into the future of supply chain management! Don’t miss out on this enlightening discussion!
Deepak Mittal
Founder & CEO
Duane Kotsen
Welcome to The Technocrats Episode 13: Weathering the Storm: Why Supply Chain Resilience is always in season? Join Deepak Mittal and Duane Kotsen as they navigate the future of supply chain and logistics in an insightful discussion.
Welcome to Technocrats Episode 12: "Reimagine Supply Chain - Trends of AI, Gen AI, & Automation Part 3!" Deepak, Mario, and Jagan discuss challenges in AI implementation. Deepak cites data quality and expertise gaps, while Mario emphasizes robust data strategies. They stress fostering innovation and talent development to overcome hurdles effectively. Tune in for insights!
In Part II of "Reimagine Supply Chain: Trends of AI, Gen AI & Automation," experts like Deepak Mittal, Mario Najera Villegas, and Jagan Reddy discuss how AI, Gen AI, and automation are reshaping logistics. Topics include AI-driven analytics for inventory, adaptive Gen AI solutions, and automation's role in efficiency and cost reduction.
Welcome to The Technocrats Episode 10: "Reimagine Supply Chain - Trends of AI, Gen AI, & Automation Part 1!" Deepak Mittal, Mario Najera Villegas, and Jagan Reddy discuss AI's impact on supply chain. Deepak reveals stats: 70% adopt Demand Forecasting, 68% focus on Route Optimization, and 59% prioritize AI in Risk Management. Mario highlights Coca-Cola's AI-driven innovations.
Join us for an insightful discussion on "Reshaping Patient Engagement and Remote Patient Monitoring: 2024's AI Trends" featuring Deepak Mittal, our esteemed host, and Mr. Gennaro Maida as our distinguished guest. Delve into the transformative impact of AI on healthcare and explore key trends shaping patient engagement and remote monitoring in 2024. Don't miss this opportunity to gain valuable insights and strategies for optimizing healthcare outcomes and patient experiences in the digital age!
Discover the potential of AI and Machine learning in supply chain optimization as Matthew shares insights on enhancing efficiency, improving inventory accuracy, and unlocking new growth opportunities. With a global inventory distortion cost of $1.1 trillion, businesses are turning to advanced technologies for solutions.
In the final episode of our precision medicine podcast series, Ms. Barri delves deep into the critical aspects of risks and pricing strategies in precision medicine and the delicate balance between patient safety, affordability, and innovation.
In the part two podcast episode of Precision Medicine, host and CEO Deepak Mittal engaged with expert guest Barri, exploring strategies to advance precision medicine, emphasizing accessibility, patient-centered approaches, and global collaboration, paving the way for equitable healthcare solutions.
In Part One Episode of Precision Medicine Ms. Blauvelt's expertise sheds light on the path to success in this field. Stay tuned for more insights in upcoming episodes. Subscribe to "The Technocrats" and stay curious about the future of healthcare and technology.
In this episode, your hosts, Deepak Mittal and Matthew Butler, discuss how AI is improving supply chains, making them more accurate and efficient, and helping businesses grow. Tune in to "The Technocrats" for a glimpse into the future!
In this episode, your hosts, Deepak Mittal and Partha Anbil, two brilliant minds at the forefront of AI research, unravel the intricate tapestry of medical breakthroughs. From diagnosis to discovery, they uncover how generative AI revolutionizes the healthcare landscape.
In this podcast episode, Deepak Mittal, Founder & CEO of NextGen Invent, interviews Ron Kyslinger, a highly respected industry expert and advisor. Ron shares his insights on adopting AI and automation, the evolving role of these technologies in supply chain initiatives, incorporating them into Walmart's operations, and managing AI risks.
Deepak Mittal, Founder & CEO of NextGen Invent, and Scott Saunders, Advisor of NextGen Invent discuss the significant role of Artificial Intelligence (AI) in supply chain management, as well as the emerging trends that supply chain managers must keep up with.
According to NCBI, every year, 6 to 7% of the world’s gross domestic product (about 8.5 to 9 trillion US dollars) is spent on healthcare. It can take up to 14 years and significantly exceed $1 billion to bring a novel drug to market. Across all therapeutic categories globally, the success rate in drug development is extremely low; for instance, 97% of cancer treatments fail during clinical trials.
The World Economic Forum projects that by 2030, AI in personalized healthcare will be valued at $188 billion worldwide. Due to the increased healthcare needs of the aging population, it is anticipated that the market will have a shortage of almost 10 million doctors, nurses, and midwives in that same year.
Sponsors and clinical researchers should anticipate using AI in clinical trials. AI software development solutions have the potential to revolutionize clinical trials by streamlining and improving the patient experience. 30% of patients leave clinical trials on average after they start, and 80% of trials fail to enroll patients by the appointed time.
Get Latest updates and industry insights every month.
